Contemporary oncoimmunology has made a real breakthrough in the therapy of cancer. According to the World Health Organization the use of the targeted preparations improved the survival rates by 15 to 20 years in the economically developed countries. The monoclonal antibodies produced either in a synthetic way or from natural sources play a leading role among the oncoimmune agents. Up-to-date approaches to the immunotherapy of cancer are described by the top chemotherapist of the N.N. Blokhin MMRCO, professor Vera A. Gorbunova in her lecture at our webpage. There is also the lecture of Prof. Andrey S. Bryukhovetskiy that describes his method of prevention of the cancer progress and relapse.

The immune and interferon status is evaluated in detail in all cancer patients and then the immune system can be corrected depending on the results of the tests and examination of the patients by Prof. Seledtsov or Dr. Borunova.

The immune system is corrected with all available immunological preparations, cell preparations based on the dendritic vaccines and cytotoxic lymphocytes or molecularly-genetically matched preparations of the allogeneic natural killer cells of the human.